An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Scorpion Therapeutics is seeking a Senior Clinical Trial Manager to lead global oncology Phase 2/3 trials (NSCLC and CRC) from start-up to closeout. The role emphasizes strategic trial planning, CRO oversight, site selection, enrollment, monitoring, risk management, data quality, and inspections readiness.
You will ensure regulatory compliance with GCP and ICH guidelines while mentoring clinical operations staff and fostering cross-functional collaboration across geographies.
Senior Clinical Trial Manager overseeing global oncology Phase 2/3 trials, including NSCLC and colorectal cancer, with responsibilities spanning study start-up to closeout, CRO oversight, and inspection readiness. The role involves strategic leadership in site selection, enrollment, monitoring, risk management, and data quality, ensuring regulatory compliance and quality standards (GCP, ICH).
Responsibilities include developing study plans, managing CRO activities, leading risk mitigation, and mentoring clinical operations staff.
Bachelor's in life sciences or related field; 8-10+ years in clinical operations, with at least 7+ years managing international oncology trials at Phase II/III; proficiency in clinical data review, regulatory interactions, and vendor oversight; ability to travel up to 20%.
Preferred skills include deep knowledge of drug development, GCP, and ICH guidelines, leadership in complex studies, and excellent organizational and communication skills.
Oncology (NSCLC, CRC), Phase 2/3, international scope, CRO management, inspection preparedness, and development of clinical trial strategies.
Travel up to 20%, based on project needs.